EUR/USD 1.14288
-0.007%
Gold 4101.96
-0.524%
Oil 72.591
1.298%
USD/JPY 161.874
-0.308%
GBP/USD 1.34193
0.084%
GBP/JPY 217.229
-0.223%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
Delta Air Lines (DAL.N) shares turned lower in pre-market trading.July 10th - Due to continuous heavy rainfall, the disaster situation in Guangxi has further worsened. The National Disaster Prevention, Mitigation and Relief Committee has raised Guangxis emergency response level from Level IV to Level III. To thoroughly implement General Secretary Xi Jinpings important instructions on flood control and disaster relief, in addition to the 110 million yuan pre-allocated on July 6th, the Ministry of Finance and the Ministry of Emergency Management urgently pre-allocated another 80 million yuan in central natural disaster relief funds on July 10th. This funding will support Guangxi in focusing on the relocation and resettlement of affected people, transitional living assistance, and the repair of damaged houses, effectively ensuring the basic living needs of the affected population. The Ministry of Finance has instructed the Guangxi Finance Department to expedite the disbursement of funds to the disaster area, ensuring the effective use of the pre-allocated funds; to strengthen the supervision of disaster relief funds, resolutely preventing any irregularities such as fund retention, misappropriation, or diversion, and ensuring that all disaster relief funds are used for the disaster area and the affected people.On July 10th, Hansoh Pharmaceutical (03692.HK) announced that its independently developed B7-H3 targeted antibody-drug conjugate, HS-20093, met the primary endpoint of overall survival (OS) in the pivotal Phase III clinical trial (ARTEMIS-008) for patients with small cell lung cancer that had progressed or relapsed after platinum-based therapy. At the pre-specified interim analysis, HS-20093 showed a statistically and clinically significant improvement in OS compared to topotecan, and consistent benefit was also observed in the secondary endpoint of progression-free survival (PFS). The safety profile was consistent with previous studies. The company will soon begin communication with regulatory agencies to advance preparations for its new drug application in China.The Reserve Bank of India reported that as of July 3, gold reserves stood at $105.21 billion, up from $102.54 billion the previous week.Spanish national gas company: In June, liquefied natural gas accounted for 50.7% of natural gas imports, while pipeline natural gas accounted for 49.3%.

Price Analysis: EUR/JPY Daily Rising Wedge Targeting 143.00

Daniel Rogers

Nov 23, 2022 16:01

 截屏2022-11-23 上午9.53.21.png

 

The EUR/JPY continues to consolidate within an ascending wedge, after ending Tuesday with tiny losses of 0.04% due to a risk-on sentiment. At the start of the Asian trading session, the EUR/JPY exchange rate is 145.48, representing a slight gain of 0.01%.

 

As noted previously, a rising wedge emerged on the EUR/JPY daily chart, with the bulk of daily lows acting as dynamic support after the 50-day Exponential Moving Average (EMA). In spite of the fact that the cross continues to move steadily, there has been less price action during the past four days. This would suggest that the EUR/JPY exchange rate is stable or that a breakout is near.

 

If the EUR/JPY reaches 146.00, it could accelerate a rally toward the year-to-date (YTD) highs near 148.40; however, buyers must first overcome crucial resistance levels. The first is the rising wedge top trendline close to 146.50, followed by the 9 November daily high at 147.11. After the psychological 148.00 is reached, the next objective will be 149.00.

 

If the EUR/JPY breaks below the rising wedge, the 50-day exponential moving average (EMA) around 144.12 would provide first support. A breach of this level will expose the 143.00 level, followed by the November 11 swing low of 142.54.

Suggestion